{"article_id": "HCA_q1_2021.txt", "article": ["revenues grew over $ 1.1 billion , or 8.7 % as compared to the prior year .", "inpatient revenues increased by 12 % .", "the acuity within our inpatient business was higher as reflected in both the case mix index , which increased 7 % and length of stay which grew by 6 % .", "additionally , commercial admits inside of our domestic operations represented 29 % of total admits , compared to 26.5 % last year .", "these two factors combined explain the 17 % increase in inpatient revenue per admissions .", "the total -- the total admits were down 4.2 % year over year .", "in comparison to 2019 , admits were down approximately 3 % , which was -- which was in line with our expectations .", "in the quarter , we treated almost 50,000 covid - 19 inpatients , which represented 10 % of total admissions .", "january with 17 % , february was 8 % , and march was down to almost 5 % .", "outpatient revenues increased 4.7 % as compared to the prior year .", "this result is better performance than the previous two quarters in which outpatient revenue was down approximately 5 % .", "but march , which had one additional weekday this year , increased by 30 % as outpatient surgery and other procedures recovered strongly .", "same facility outpatient surgery volumes grew 2.3 % as compared to last year .", "as compared to 2019 , they declined 3 % .", "e.r. visits declined 18 % .", "visits were down 19 % compared to 2019 .", "diluted earnings per share , excluding losses and gains on sales as well as losses on debt retirement , increase 78 % to $ 4.14 .", "as a result of the strong operating performance in the quarter , our cash flow from operations was $ 1.99 billion , as compared to $ 1.375 billion in the first quarter of 2020 .", "capital spending for the quarter was $ 654 million and we completed just over $ 1.5 billion of share repurchases during the quarter .", "we have approximately $ 7.3 billion remaining on our authorization and consistent with our year - end discussion .", "our debt to adjusted ebitda leverage was 2.85 times and we had approximately $ 5.6 billion of available liquidity at the end of the quarter .", "we expect revenue to range between $ 54 billion and $ 55.5 billion .", "we expect full - year ebitda to range between $ 10.85 billion and $ 11.35 billion .", "we expect full - year diluted earnings per share to range between $ 13.30 and $ 14.30 .", "and our capital spending target remains at approximately $ 3.7 billion ."], "summary_gold": "q1 earnings per share $ 4.14 .<q>sees fy earnings per share $ 13.30 to $ 14.30 .<q>qtrly same facility admissions declined 4.2 percent and same facility equivalent admissions declined 6.5 percent .<q>sees 2021 revenues $ 54.0 to $ 55.5 billion .", "summary_pred": "visits were down 19 % compared to 2019 .<q>revenues grew over $ 1.1 billion , or 8.7 % as compared to the prior year .<q>diluted earnings per share , excluding losses and gains on sales as well as losses on debt retirement , increase 78 % to $ 4.14 .<q>we have approximately $ 7.3 billion remaining on our authorization and consistent with our year - end discussion .<q>these two factors combined explain the 17 % increase in inpatient revenue per admissions .<q>capital spending for the quarter was $ 654 million and we completed just over $ 1.5 billion of share repurchases during the quarter .<q>the total -- the total admits were down 4.2 % year over year .<q>the acuity within our inpatient business was higher as reflected in both the case mix index , which increased 7 % and length of stay which grew by 6 % .<q>additionally , commercial admits inside of our domestic operations represented 29 % of total admits , compared to 26.5 % last year .<q>e.r. visits declined 18 % .<q>and our capital spending target remains at approximately $ 3.7 billion .<q>we expect revenue to range between $ 54 billion and $ 55.5 billion .<q>inpatient revenues increased by 12 % .<q>but march , which had one additional weekday this year , increased by 30 % as outpatient surgery and other procedures recovered strongly .<q>this result is better performance than the previous two quarters in which outpatient revenue was down approximately 5 % .", "len_article": 25, "len_summary_gold": 4, "len_summary_pred": 15, "len_sent_scores": 25}